Data as of Dec 09
| -0.18 / -2.47%|
The 4 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +26.40% increase from the last price of 7.12.
The current consensus among 4 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.